These in vivo and in vitro findings demonstrate for the first time that Sirt6 has a crucial role in the maintenance of glomerular function, and consequently, may be an important, potentially new therapeutic target for renal diseases associated with aging. This evidence concerns the gene SIRT6 and kidney disorder.